Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China · Delayed Price · Currency is CNY 7.31
+0.06 (0.83%)
At close: Mar 27, 2026
SHA:600866 Market Cap
SHA:600866 has a market cap or net worth of 12.15 billion as of March 27, 2026. Its market cap has increased by 14.22% in one year.
Market Cap
12.15B
Enterprise Value
15.12B
Revenue
16.62B
Ranking
n/a
PE Ratio
9.48
Stock Price
7.31
Market Cap Chart
Since August 25, 2006, SHA:600866's market cap has increased from 1.16B to 12.15B, an increase of 945.16%. That is a compound annual growth rate of 12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 12.15B | 5.18% |
| Dec 31, 2025 | 11.55B | 7.42% |
| Dec 31, 2024 | 10.75B | 38.84% |
| Dec 29, 2023 | 7.74B | -21.42% |
| Dec 30, 2022 | 9.85B | 113.65% |
| Dec 31, 2021 | 4.61B | 25.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabwell (Shanghai) Bioscience | 14.51B |
| Staidson (Beijing) BioPharmaceuticals | 13.26B |
| Tibet Cheezheng Tibetan Medicine | 13.02B |
| Chengzhi | 12.65B |
| Pacific Shuanglin Bio-pharmacy | 12.47B |
| Chengdu Olymvax Biopharmaceuticals | 12.07B |
| Chengdu Easton Biopharmaceuticals | 11.57B |
| Hualan Biological Vaccine | 11.41B |